GB0922553D0 - Prognostic marker - Google Patents

Prognostic marker

Info

Publication number
GB0922553D0
GB0922553D0 GBGB0922553.3A GB0922553A GB0922553D0 GB 0922553 D0 GB0922553 D0 GB 0922553D0 GB 0922553 A GB0922553 A GB 0922553A GB 0922553 D0 GB0922553 D0 GB 0922553D0
Authority
GB
United Kingdom
Prior art keywords
prognostic marker
prognostic
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0922553.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fusion Antibodies Ltd
Original Assignee
Fusion Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fusion Antibodies Ltd filed Critical Fusion Antibodies Ltd
Priority to GBGB0922553.3A priority Critical patent/GB0922553D0/en
Publication of GB0922553D0 publication Critical patent/GB0922553D0/en
Priority to PCT/GB2010/052205 priority patent/WO2011077165A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G01N33/57535—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
GBGB0922553.3A 2009-12-23 2009-12-23 Prognostic marker Ceased GB0922553D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0922553.3A GB0922553D0 (en) 2009-12-23 2009-12-23 Prognostic marker
PCT/GB2010/052205 WO2011077165A1 (en) 2009-12-23 2010-12-23 Prognostic marker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0922553.3A GB0922553D0 (en) 2009-12-23 2009-12-23 Prognostic marker

Publications (1)

Publication Number Publication Date
GB0922553D0 true GB0922553D0 (en) 2010-02-10

Family

ID=41716899

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0922553.3A Ceased GB0922553D0 (en) 2009-12-23 2009-12-23 Prognostic marker

Country Status (2)

Country Link
GB (1) GB0922553D0 (en)
WO (1) WO2011077165A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3920358A1 (en) 1989-06-22 1991-01-17 Behringwerke Ag BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
DK0617706T3 (en) 1991-11-25 2001-11-12 Enzon Inc Multivalent antigen-binding proteins
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
FI980647A0 (en) * 1998-03-23 1998-03-23 Aboatech Ltd For the purposes of diagnostic diagnostics, for the diagnosis and differential diagnosis
NZ563273A (en) 2005-04-09 2010-02-26 Fusion Antibodies Ltd Cathepsin S antibody
GB0620255D0 (en) 2006-10-12 2006-11-22 Fusion Antibodies Ltd Antibody and uses thereof
CA2648947A1 (en) * 2006-04-10 2007-11-15 Fusion Antibodies Limited Therapy targeting cathepsin s

Also Published As

Publication number Publication date
WO2011077165A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
GB0919675D0 (en) Matching information times
EP2430610A4 (en) Alterable account number
EP2456311A4 (en) Substituted imidazotriazines
GB201001079D0 (en) Prognostic assay
ZA201108565B (en) Substituted piperidnes
GB0903417D0 (en) Biomarkers
GB0921329D0 (en) Biomarker
GB0910088D0 (en) Location arrangements
GB0908071D0 (en) Marker
GB0905964D0 (en) Marker
GB0915736D0 (en) Biomarkers
GB0822155D0 (en) Marker
IL217333A0 (en) Biomarker
GB0903391D0 (en) Biomarkers
GB0912175D0 (en) Biomarker
GB0909926D0 (en) Environmental features
GB0922236D0 (en) Biomarkers
GB0922553D0 (en) Prognostic marker
GB0908544D0 (en) Downpipe
AU4612P (en) Greenjewel Dracaena deremensis
AU4611P (en) 2004027j Dracaena deremensis
AU4610P (en) Jadejewel Dracaena deremensis
AU4240P (en) Tuckerbox xTriticosecale
AU4924P (en) Bonscablue Scaevola aemula
GB0922227D0 (en) Biomarkers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)